Alfred L Hurwitz, MD
Gastroenterology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 3 carriers
- Office
- 1
Offices
1 location
Plans that list them
13 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hurwitz’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G20286 · Current
Licensed to practise in California · since 1971 · expires 2027-03-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$73,196
Medicare paid this office $73,196 for 244 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 158 | $26,826 | $112 |
| Long return visit (40+ min) | 147 | $25,943 | $156 |
| Short return visit (20+ min) | 74 | $15,156 | $80 |
| New patient visit (60+ min) | 22 | $4,163 | $189 |
Who their Medicare patients are
244 Original Medicare patients in 2024. Average age 78 · Women 64% · Health risk score 1.20. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Coronary heart disease 37% · Diabetes 28% · Atrial fibrillation 25% · Cancer 24% · Chronic kidney disease 20% · Stroke 17% · Depression 16% · Heart failure 14% · COPD 13% · Dementia 6%.
The office billed $108,232, Medicare allowed $93,808 and paid $73,196; for 628 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 244 | 628 | 78 | 1.20 | $108,232 | $73,196 |
| 2023 | 270 | 627 | 77 | 1.14 | $115,785 | $84,087 |
| 2022 | 270 | 687 | 78 | 1.19 | $119,794 | $87,426 |
| 2021 | 300 | 789 | 77 | 1.09 | $136,534 | $101,493 |
| 2020 | 292 | 699 | 77 | 1.17 | $104,801 | $63,736 |
| 2019 | 445 | 1,053 | 76 | 1.14 | $233,938 | $107,019 |
| 2018 | 536 | 1,127 | 76 | 1.11 | $249,020 | $107,413 |
| 2017 | 545 | 1,110 | 75 | 1.11 | $244,410 | $97,786 |
| 2016 | 540 | 1,053 | 76 | 1.13 | $145,419 | $94,604 |
| 2015 | 513 | 1,024 | 76 | 1.15 | $142,070 | $98,212 |
| 2014 | 532 | 1,160 | 75 | 1.04 | $161,196 | $113,320 |
| 2013 | 584 | 1,264 | 75 | 1.04 | $177,345 | $123,126 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Long return visit (40+ min) | 155 | $36,128 | $169 |
| Return visit (30+ min) | 141 | $23,426 | $121 |
| Short return visit (20+ min) | 70 | $12,837 | $86 |
| New patient visit (60+ min) | 30 | $6,155 | $205 |
| New patient visit (45+ min) | 34 | $5,344 | $157 |
2022: 6 services
| Return visit (30+ min) | 155 | $33,480 | $121 |
| Long return visit (40+ min) | 156 | $32,683 | $167 |
| Short return visit (20+ min) | 68 | $12,073 | $87 |
| New patient visit (45+ min) | 27 | $4,263 | $158 |
| New patient visit (60+ min) | 17 | $3,271 | $192 |
| Short return visit | 28 | $1,657 | $53 |
2021: 6 services
| Long return visit (40+ min) | 162 | $39,481 | $171 |
| Return visit (30+ min) | 179 | $35,310 | $122 |
| Short return visit (20+ min) | 82 | $14,972 | $89 |
| New patient visit (45+ min) | 35 | $5,473 | $156 |
| New patient visit (60+ min) | 17 | $3,528 | $208 |
| Short return visit | 34 | $2,575 | $56 |
2020: 6 services
| Return visit (30+ min) | 157 | $22,933 | $94 |
| Long return visit (40+ min) | 139 | $20,037 | $128 |
| Short return visit (20+ min) | 98 | $11,038 | $69 |
| Short return visit | 71 | $4,268 | $41 |
| New patient visit (60+ min) | 18 | $3,345 | $186 |
| New patient visit (45+ min) | 15 | $2,070 | $138 |
2019: 10 services
| Return visit (30+ min) | 246 | $35,955 | $96 |
| Long return visit (40+ min) | 178 | $26,963 | $125 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 59 | $11,989 | $203 |
| Short return visit (20+ min) | 95 | $6,780 | $63 |
| New patient visit (45+ min) | 41 | $5,939 | $145 |
| New patient visit (60+ min) | 34 | $5,890 | $173 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 40 | $3,684 | $92 |
| Diagnostic exam of large bowel using a flexible endoscope | 21 | $3,320 | $158 |
| Biopsy of large bowel using a flexible endoscope | 13 | $2,480 | $177 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 121 | $535 | $4 |
2018: 10 services
| Return visit (30+ min) | 317 | $38,441 | $88 |
| Long return visit (40+ min) | 116 | $15,918 | $126 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 57 | $11,751 | $206 |
| Short return visit (20+ min) | 146 | $10,144 | $59 |
| New patient visit (45+ min) | 55 | $7,899 | $144 |
| New patient visit (60+ min) | 44 | $7,794 | $177 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 56 | $5,357 | $96 |
| Biopsy of large bowel using a flexible endoscope | 29 | $5,219 | $180 |
| Diagnostic exam of large bowel using a flexible endoscope | 17 | $2,484 | $146 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 122 | $522 | $4 |
2017: 11 services
| Return visit (30+ min) | 381 | $44,619 | $88 |
| Short return visit (20+ min) | 173 | $12,473 | $59 |
| Long return visit (40+ min) | 56 | $7,297 | $118 |
| New patient visit (60+ min) | 37 | $6,514 | $176 |
| Diagnostic exam of large bowel using a flexible endoscope | 37 | $5,669 | $153 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 60 | $5,636 | $94 |
| Biopsy of large bowel using a flexible endoscope | 36 | $5,320 | $148 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 18 | $3,704 | $206 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,885 | $206 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 69 | $326 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 20 | $324 | $11 |
2016: 8 services
| Return visit (30+ min) | 410 | $46,100 | $83 |
| Short return visit (20+ min) | 186 | $12,685 | $54 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 30 | $6,178 | $206 |
| New patient visit (60+ min) | 37 | $5,910 | $160 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 63 | $5,473 | $87 |
| Long return visit (40+ min) | 43 | $4,921 | $109 |
| Biopsy of large bowel using a flexible endoscope | 22 | $3,952 | $180 |
| Diagnostic exam of large bowel using a flexible endoscope | 20 | $3,151 | $158 |
2015: 9 services
| Return visit (30+ min) | 404 | $46,606 | $87 |
| Short return visit (20+ min) | 175 | $12,627 | $54 |
| Diagnostic exam of large bowel using a flexible endoscope | 41 | $7,198 | $176 |
| New patient visit (60+ min) | 37 | $5,839 | $158 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 55 | $5,808 | $106 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 25 | $5,781 | $231 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $3,243 | $270 |
| Long return visit (40+ min) | 24 | $3,149 | $117 |
| Biopsy of large bowel using a flexible endoscope | 12 | $2,625 | $219 |
2014: 10 services
| Return visit (30+ min) | 379 | $44,280 | $84 |
| Short return visit (20+ min) | 233 | $17,096 | $55 |
| Diagnostic exam of large bowel using a flexible endoscope | 56 | $10,535 | $188 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 39 | $9,293 | $238 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 79 | $8,468 | $106 |
| New patient visit (60+ min) | 34 | $5,589 | $164 |
| Removal of polyps or growths in large bowel using an endoscope | 16 | $4,649 | $291 |
| Biopsy of large bowel using a flexible endoscope | 19 | $3,957 | $208 |
| New patient visit (45+ min) | 13 | $1,621 | $125 |
| Long return visit (40+ min) | 14 | $1,292 | $92 |
2013: 12 services
| Return visit (30+ min) | 325 | $34,281 | $83 |
| Short return visit (20+ min) | 332 | $26,858 | $55 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 98 | $12,956 | $131 |
| Diagnostic exam of large bowel using a flexible endoscope | 66 | $12,298 | $186 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 37 | $8,889 | $240 |
| Removal of polyps or growths in large bowel using an endoscope | 30 | $8,335 | $278 |
| New patient visit (60+ min) | 35 | $5,900 | $169 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | $3,601 | $240 |
| Biopsy of large bowel using a flexible endoscope | 17 | $3,356 | $197 |
| New patient visit (45+ min) | 15 | $1,970 | $131 |
| Long return visit (40+ min) | 13 | $1,667 | $111 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 11 | $556 | $51 |
Drugs they prescribed that Part D paid
$398,106
Pharmacies billed $398,106 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
539 generic and 116 brand-name prescriptions · $398,106 in drug cost · 47 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Creon | 23 | $52,919 | $2,301 |
| Xifaxan | 13 | $39,544 | $3,042 |
| Linzess | 27 | $19,354 | $717 |
| Mesalamine | 20 | $16,367 | $818 |
| Balsalazide Disodium | 31 | $9,520 | $307 |
See all 21 drugs
| Creon | 23 | $52,919 | $2,301 |
| Xifaxan | 13 | $39,544 | $3,042 |
| Linzess | 27 | $19,354 | $717 |
| Mesalamine | 20 | $16,367 | $818 |
| Balsalazide Disodium | 31 | $9,520 | $307 |
| Dexlansoprazole Dr | 28 | $7,044 | $252 |
| Colestipol | 16 | $1,916 | $120 |
| Pantoprazole | 106 | $1,798 | $17 |
| Cholestyramine | 12 | $1,176 | $98 |
| Lansoprazole | 35 | $987 | $28 |
| Omeprazole | 75 | $952 | $13 |
| Esomeprazole Magnesium | 22 | $717 | $33 |
| Rabeprazole | 14 | $609 | $44 |
| Hyoscyamine Sulfate | 11 | $357 | $32 |
| Dicyclomine | 20 | $246 | $12 |
| Ondansetron Odt | 11 | $202 | $18 |
| Amoxicillin-Clavulanate Potass | 13 | $196 | $15 |
| Diphenoxylate-Atropine | 12 | $183 | $15 |
| Metoclopramide | 14 | $178 | $13 |
| Fluconazole | 11 | $50 | $5 |
| Klor-Con 10 | 11 | $11 | $1 |
Year by year
| 2024 | 666 | 139 | None | 17% | $398,106 |
| 2023 | 693 | 160 | 0% (0) | None | $464,843 |
| 2022 | 790 | 151 | None | None | $404,923 |
| 2021 | 908 | 169 | None | 28% | $418,931 |
| 2020 | 1,022 | 183 | None | 24% | $322,623 |
| 2019 | 1,287 | 285 | 1% (14) | 24% | $346,368 |
| 2018 | 1,414 | 321 | None | 23% | $479,163 |
| 2017 | 1,388 | 302 | None | None | $405,274 |
| 2016 | 1,622 | 344 | 1% (11) | None | $318,530 |
| 2015 | 1,657 | 317 | None | None | $225,365 |
| 2014 | 1,634 | 333 | 1% (14) | None | $234,694 |
| 2013 | 1,523 | 328 | 2% (27) | 37% | $258,220 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Creon | 24 | $50,410 | $2,100 |
| Xifaxan | 13 | $42,938 | $3,303 |
| Linzess | 34 | $27,464 | $808 |
| Mesalamine | 18 | $23,256 | $1,292 |
| Dexlansoprazole Dr | 36 | $15,305 | $425 |
| Balsalazide Disodium | 31 | $12,696 | $410 |
| Cholestyramine | 12 | $3,755 | $313 |
| Pantoprazole | 123 | $2,054 | $17 |
| Lansoprazole | 34 | $1,654 | $49 |
| Colestipol | 11 | $1,537 | $140 |
| Rabeprazole | 15 | $1,290 | $86 |
| Omeprazole | 72 | $1,007 | $14 |
| Esomeprazole Magnesium | 17 | $861 | $51 |
| Dicyclomine | 22 | $404 | $18 |
| Amitriptyline | 11 | $320 | $29 |
| Ondansetron Odt | 13 | $191 | $15 |
| Klor-Con 10 | 12 | $189 | $16 |
| Famotidine | 17 | $187 | $11 |
| Metoclopramide | 12 | $181 | $15 |
| Amoxicillin-Clavulanate Potass | 11 | $46 | $4 |
| Fluconazole | 12 | $35 | $3 |
2022: 24 drugs
| Creon | 25 | $83,761 | $3,350 |
| Humira | 11 | $68,105 | $6,191 |
| Xifaxan | 14 | $41,670 | $2,976 |
| Linzess | 47 | $31,146 | $663 |
| Mesalamine | 17 | $21,223 | $1,248 |
| Balsalazide Disodium | 30 | $15,650 | $522 |
| Dexilant | 12 | $8,676 | $723 |
| Dexlansoprazole Dr | 17 | $7,937 | $467 |
| Pantoprazole | 132 | $3,556 | $27 |
| Cholestyramine | 13 | $3,229 | $248 |
| Rabeprazole | 12 | $1,861 | $155 |
| Omeprazole | 97 | $1,164 | $12 |
| Entecavir | 16 | $1,115 | $70 |
| Celecoxib | 11 | $1,093 | $99 |
| Lansoprazole | 27 | $948 | $35 |
| Amitriptyline | 25 | $662 | $26 |
| Glycopyrrolate | 18 | $605 | $34 |
| Esomeprazole Magnesium | 13 | $477 | $37 |
| Dicyclomine | 20 | $370 | $18 |
| Ondansetron Odt | 17 | $234 | $14 |
| Klor-Con 10 | 13 | $233 | $18 |
| Metoclopramide | 19 | $193 | $10 |
| Furosemide | 14 | $55 | $4 |
| Amoxicillin | 11 | $15 | $1 |
2021: 26 drugs
| Creon | 20 | $65,222 | $3,261 |
| Humira | 11 | $63,812 | $5,801 |
| Xifaxan | 15 | $40,168 | $2,678 |
| Linzess | 63 | $37,100 | $589 |
| Dexilant | 62 | $35,635 | $575 |
| Mesalamine | 32 | $23,748 | $742 |
| Viberzi | 11 | $22,355 | $2,032 |
| Mesalamine Er | 17 | $12,928 | $760 |
| Balsalazide Disodium | 26 | $11,183 | $430 |
| Cholestyramine | 17 | $4,011 | $236 |
| Pantoprazole | 120 | $3,182 | $27 |
| Omeprazole | 122 | $2,169 | $18 |
| Rabeprazole | 11 | $1,893 | $172 |
| Entecavir | 16 | $1,627 | $102 |
| Esomeprazole Magnesium | 13 | $1,490 | $115 |
| Ondansetron Odt | 13 | $655 | $50 |
| Dicyclomine | 36 | $543 | $15 |
| Hydrocortisone | 11 | $536 | $49 |
| Lansoprazole | 16 | $345 | $22 |
| Amitriptyline | 30 | $296 | $10 |
| Klor-Con 10 | 12 | $219 | $18 |
| Prednisone | 15 | $208 | $14 |
| Glycopyrrolate | 16 | $157 | $10 |
| Furosemide | 14 | $51 | $4 |
| Triamterene-Hydrochlorothiazid | 11 | $44 | $4 |
| Amoxicillin | 15 | $23 | $2 |
2020: 25 drugs
| Xifaxan | 17 | $41,697 | $2,453 |
| Dexilant | 50 | $30,564 | $611 |
| Linzess | 58 | $30,368 | $524 |
| Viberzi | 12 | $26,615 | $2,218 |
| Mesalamine | 28 | $22,431 | $801 |
| Balsalazide Disodium | 31 | $13,468 | $434 |
| Mesalamine Er | 11 | $5,249 | $477 |
| Pantoprazole | 183 | $4,043 | $22 |
| Cholestyramine | 21 | $3,642 | $173 |
| Omeprazole | 170 | $3,261 | $19 |
| Rabeprazole | 17 | $2,745 | $161 |
| Esomeprazole Magnesium | 15 | $2,258 | $151 |
| Entecavir | 24 | $1,462 | $61 |
| Famotidine | 40 | $529 | $13 |
| Hydrocortisone | 11 | $341 | $31 |
| Dicyclomine | 17 | $336 | $20 |
| Amitriptyline | 16 | $243 | $15 |
| Klor-Con 10 | 12 | $200 | $17 |
| Prednisone | 13 | $184 | $14 |
| Famotidine | 12 | $168 | $14 |
| Diltiazem 24hr Er (Cd) | 12 | $119 | $10 |
| Furosemide | 17 | $74 | $4 |
| Triamterene-Hydrochlorothiazid | 13 | $52 | $4 |
| Amlodipine Besylate | 14 | $48 | $3 |
| Amoxicillin | 13 | $23 | $2 |
2019: 32 drugs
| Viberzi | 17 | $41,266 | $2,427 |
| Linzess | 74 | $40,984 | $554 |
| Xifaxan | 14 | $33,210 | $2,372 |
| Dexilant | 49 | $29,470 | $601 |
| Apriso | 25 | $20,383 | $815 |
| Mesalamine | 20 | $19,583 | $979 |
| Balsalazide Disodium | 43 | $10,658 | $248 |
| Budesonide Ec | 11 | $6,913 | $628 |
| Omeprazole | 233 | $4,623 | $20 |
| Pantoprazole | 205 | $4,526 | $22 |
| Mercaptopurine | 14 | $2,672 | $191 |
| Rabeprazole | 18 | $2,670 | $148 |
| Cholestyramine | 19 | $2,576 | $136 |
| Esomeprazole Magnesium | 11 | $1,530 | $139 |
| Entecavir | 19 | $1,193 | $63 |
| Hydrocortisone | 13 | $1,124 | $86 |
| Diphenoxylate-Atropine | 13 | $965 | $74 |
| Peg 3350-Electrolyte | 46 | $881 | $19 |
| Ciprofloxacin | 21 | $699 | $33 |
| Gavilyte-N | 36 | $643 | $18 |
| Dicyclomine | 25 | $432 | $17 |
| Lansoprazole | 20 | $391 | $20 |
| Ranitidine | 11 | $385 | $35 |
| Ondansetron | 12 | $287 | $24 |
| Famotidine | 21 | $285 | $14 |
| Amitriptyline | 16 | $260 | $16 |
| Furosemide | 17 | $192 | $11 |
| Prednisone | 12 | $188 | $16 |
| Amlodipine Besylate | 16 | $85 | $5 |
| Tramadol | 14 | $81 | $6 |
| Triamterene-Hydrochlorothiazid | 12 | $48 | $4 |
| Amoxicillin | 15 | $41 | $3 |
2018: 34 drugs
| Dexilant | 73 | $33,094 | $453 |
| Viberzi | 18 | $30,620 | $1,701 |
| Xifaxan | 14 | $26,654 | $1,904 |
| Mesalamine | 23 | $23,133 | $1,006 |
| Linzess | 51 | $22,815 | $447 |
| Apriso | 16 | $13,751 | $859 |
| Budesonide Ec | 29 | $13,633 | $470 |
| Balsalazide Disodium | 50 | $13,082 | $262 |
| Entecavir | 12 | $7,773 | $648 |
| Pantoprazole | 242 | $4,192 | $17 |
| Omeprazole | 223 | $4,098 | $18 |
| Cholestyramine | 30 | $3,817 | $127 |
| Mercaptopurine | 15 | $3,423 | $228 |
| Diphenoxylate-Atropine | 19 | $1,893 | $100 |
| Esomeprazole Magnesium | 12 | $1,844 | $154 |
| Rabeprazole | 12 | $1,544 | $129 |
| Peg 3350-Electrolyte | 67 | $1,168 | $17 |
| Ciprofloxacin | 18 | $665 | $37 |
| Lansoprazole | 15 | $558 | $37 |
| Gavilyte-N | 33 | $522 | $16 |
| Ondansetron | 30 | $500 | $17 |
| Dicyclomine | 36 | $410 | $11 |
| Klor-Con 10 | 12 | $277 | $23 |
| Prednisone | 21 | $237 | $11 |
| Glycopyrrolate | 11 | $201 | $18 |
| Furosemide | 16 | $189 | $12 |
| Famotidine | 23 | $170 | $7 |
| Metoclopramide | 19 | $155 | $8 |
| Zolpidem | 12 | $101 | $8 |
| Famotidine | 11 | $88 | $8 |
| Metronidazole | 13 | $88 | $7 |
| Amoxicillin | 11 | $59 | $5 |
| Amlodipine Besylate | 17 | $53 | $3 |
| Triamterene-Hydrochlorothiazid | 12 | $47 | $4 |
2017: 34 drugs
| Dexilant | 89 | $34,844 | $392 |
| Lialda | 18 | $27,140 | $1,508 |
| Viberzi | 12 | $14,746 | $1,229 |
| Budesonide Ec | 20 | $12,731 | $637 |
| Aciphex | 11 | $11,766 | $1,070 |
| Apriso | 16 | $11,203 | $700 |
| Amitiza | 34 | $10,099 | $297 |
| Balsalazide Disodium | 43 | $9,964 | $232 |
| Linzess | 19 | $8,552 | $450 |
| Mesalamine | 11 | $8,150 | $741 |
| Pentasa | 11 | $8,032 | $730 |
| Nexium | 11 | $4,631 | $421 |
| Pantoprazole | 247 | $3,620 | $15 |
| Omeprazole | 173 | $3,594 | $21 |
| Mercaptopurine | 17 | $2,959 | $174 |
| Cholestyramine | 26 | $2,918 | $112 |
| Esomeprazole Magnesium | 23 | $2,454 | $107 |
| Diphenoxylate-Atropine | 22 | $2,163 | $98 |
| Rabeprazole | 12 | $1,725 | $144 |
| Hydrocortisone | 15 | $1,566 | $104 |
| Peg 3350-Electrolyte | 61 | $888 | $15 |
| Ondansetron | 32 | $533 | $17 |
| Dicyclomine | 37 | $516 | $14 |
| Levofloxacin | 12 | $454 | $38 |
| Gavilyte-N | 23 | $384 | $17 |
| Famotidine | 51 | $339 | $7 |
| Klor-Con 10 | 13 | $339 | $26 |
| Ciprofloxacin | 17 | $264 | $16 |
| Amitriptyline | 22 | $263 | $12 |
| Prednisone | 21 | $257 | $12 |
| Furosemide | 15 | $175 | $12 |
| Metoclopramide | 22 | $167 | $8 |
| Amlodipine Besylate | 24 | $66 | $3 |
| Triamterene-Hydrochlorothiazid | 12 | $44 | $4 |
2016: 37 drugs
| Dexilant | 120 | $37,372 | $311 |
| Xifaxan | 13 | $24,110 | $1,855 |
| Lialda | 13 | $20,902 | $1,608 |
| Budesonide Ec | 16 | $9,884 | $618 |
| Apriso | 16 | $9,509 | $594 |
| Nexium | 21 | $8,128 | $387 |
| Linzess | 12 | $7,588 | $632 |
| Balsalazide Disodium | 38 | $7,470 | $197 |
| Amitiza | 30 | $6,529 | $218 |
| Esomeprazole Magnesium | 15 | $5,664 | $378 |
| Colcrys | 12 | $4,809 | $401 |
| Pantoprazole | 329 | $4,447 | $14 |
| Cholestyramine | 44 | $3,710 | $84 |
| Omeprazole | 199 | $3,515 | $18 |
| Rabeprazole | 15 | $2,573 | $172 |
| Mercaptopurine | 15 | $2,057 | $137 |
| Diphenoxylate-Atropine | 20 | $1,400 | $70 |
| Peg 3350-Electrolyte | 59 | $911 | $15 |
| Lansoprazole | 12 | $862 | $72 |
| Ondansetron | 22 | $538 | $24 |
| Polyethylene Glycol 3350 | 14 | $533 | $38 |
| Ciprofloxacin | 35 | $528 | $15 |
| Dicyclomine | 35 | $524 | $15 |
| Amitriptyline | 23 | $492 | $21 |
| Famotidine | 54 | $484 | $9 |
| Gavilyte-N | 23 | $421 | $18 |
| Lactulose | 11 | $382 | $35 |
| Klor-Con 10 | 12 | $324 | $27 |
| Colestipol | 11 | $311 | $28 |
| Prednisone | 26 | $265 | $10 |
| Levofloxacin | 17 | $210 | $12 |
| Metoclopramide | 25 | $171 | $7 |
| Furosemide | 17 | $154 | $9 |
| Metronidazole | 15 | $132 | $9 |
| Zolpidem | 15 | $130 | $9 |
| Amlodipine Besylate | 28 | $111 | $4 |
| Triamterene-Hydrochlorothiazid | 15 | $44 | $3 |
2015: 37 drugs
| Dexilant | 123 | $36,522 | $297 |
| Lialda | 17 | $28,536 | $1,679 |
| Nexium | 36 | $15,257 | $424 |
| Apriso | 13 | $9,628 | $741 |
| Linzess | 16 | $9,525 | $595 |
| Protonix | 14 | $8,258 | $590 |
| Balsalazide Disodium | 24 | $7,084 | $295 |
| Pantoprazole | 365 | $5,085 | $14 |
| Omeprazole | 180 | $3,651 | $20 |
| Celecoxib | 27 | $3,636 | $135 |
| Spiriva | 11 | $3,475 | $316 |
| Cholestyramine | 44 | $3,389 | $77 |
| Mercaptopurine | 29 | $3,369 | $116 |
| Rabeprazole | 26 | $2,836 | $109 |
| Lansoprazole | 20 | $2,160 | $108 |
| Diphenoxylate-Atropine | 26 | $1,552 | $60 |
| Hydrocortisone | 15 | $1,438 | $96 |
| Peg 3350-Electrolyte | 58 | $958 | $17 |
| Amitriptyline | 37 | $696 | $19 |
| Potassium Chloride | 14 | $681 | $49 |
| Ranitidine | 19 | $539 | $28 |
| Gavilyte-N | 26 | $506 | $19 |
| Ondansetron | 15 | $447 | $30 |
| Dicyclomine | 45 | $433 | $10 |
| Ciprofloxacin | 23 | $358 | $16 |
| Klor-Con 10 | 12 | $343 | $29 |
| Metoclopramide | 28 | $243 | $9 |
| Nortriptyline | 14 | $239 | $17 |
| Furosemide | 31 | $216 | $7 |
| Amlodipine Besylate | 31 | $194 | $6 |
| Prednisone | 16 | $183 | $11 |
| Levofloxacin | 18 | $148 | $8 |
| Sertraline | 13 | $145 | $11 |
| Metronidazole | 12 | $100 | $8 |
| Carvedilol | 12 | $77 | $6 |
| Lisinopril | 12 | $33 | $3 |
| Triamterene-Hydrochlorothiazid | 11 | $21 | $2 |
2014: 38 drugs
| Dexilant | 128 | $33,368 | $261 |
| Nexium | 70 | $29,053 | $415 |
| Lialda | 12 | $24,486 | $2,040 |
| Budesonide Ec | 13 | $17,508 | $1,347 |
| Creon | 14 | $16,054 | $1,147 |
| Aciphex | 11 | $8,125 | $739 |
| Amitiza | 17 | $7,637 | $449 |
| Balsalazide Disodium | 18 | $5,937 | $330 |
| Rabeprazole | 25 | $5,394 | $216 |
| Pantoprazole | 328 | $5,246 | $16 |
| Omeprazole | 198 | $4,139 | $21 |
| Celebrex | 23 | $4,090 | $178 |
| Lansoprazole | 22 | $2,851 | $130 |
| Mercaptopurine | 30 | $2,534 | $84 |
| Cholestyramine | 25 | $1,745 | $70 |
| Peg-3350 | 60 | $1,051 | $18 |
| Moviprep | 11 | $873 | $79 |
| Polyethylene Glycol 3350 | 17 | $763 | $45 |
| Diphenoxylate-Atropine | 32 | $746 | $23 |
| Zolpidem Tartrate Er | 12 | $702 | $59 |
| Potassium Chloride | 12 | $695 | $58 |
| Gavilyte-N | 29 | $499 | $17 |
| Ranitidine | 19 | $488 | $26 |
| Amitriptyline | 41 | $415 | $10 |
| Dicyclomine | 33 | $389 | $12 |
| Levofloxacin | 28 | $375 | $13 |
| Klor-Con 10 | 13 | $373 | $29 |
| Ondansetron | 13 | $276 | $21 |
| Metoclopramide | 25 | $257 | $10 |
| Prednisone | 18 | $236 | $13 |
| Metronidazole | 24 | $198 | $8 |
| Furosemide | 28 | $192 | $7 |
| Ciprofloxacin | 16 | $167 | $10 |
| Amlodipine Besylate | 22 | $142 | $6 |
| Paroxetine | 11 | $123 | $11 |
| Carvedilol | 12 | $112 | $9 |
| Sertraline | 11 | $108 | $10 |
| Lisinopril | 12 | $39 | $3 |
2013: 32 drugs
| Nexium | 79 | $29,429 | $373 |
| Dexilant | 121 | $27,990 | $231 |
| Lialda | 16 | $26,160 | $1,635 |
| Lotronex | 11 | $22,364 | $2,033 |
| Aciphex | 25 | $15,201 | $608 |
| Protonix | 16 | $14,249 | $891 |
| Amitiza | 36 | $11,432 | $318 |
| Creon | 11 | $11,211 | $1,019 |
| Colcrys | 18 | $6,124 | $340 |
| Pantoprazole | 263 | $5,452 | $21 |
| Lansoprazole | 40 | $5,058 | $126 |
| Omeprazole | 217 | $4,998 | $23 |
| Mercaptopurine | 23 | $2,941 | $128 |
| Balsalazide Disodium | 14 | $2,381 | $170 |
| Cymbalta | 12 | $2,352 | $196 |
| Zoloft | 13 | $1,972 | $152 |
| Peg-3350 With Flavor Packs | 75 | $1,359 | $18 |
| Glycopyrrolate | 22 | $1,322 | $60 |
| Zolpidem Tartrate Er | 13 | $1,103 | $85 |
| Polyethylene Glycol 3350 | 21 | $1,001 | $48 |
| Cholestyramine | 20 | $916 | $46 |
| Moviprep | 11 | $785 | $71 |
| Gavilyte-N | 29 | $552 | $19 |
| Diphenoxylate-Atropine | 25 | $509 | $20 |
| Amitriptyline | 49 | $383 | $8 |
| Metoclopramide | 28 | $348 | $12 |
| Klor-Con 10 | 12 | $344 | $29 |
| Amlodipine Besylate | 20 | $285 | $14 |
| Dicyclomine | 13 | $236 | $18 |
| Tramadol | 12 | $171 | $14 |
| Ciprofloxacin | 15 | $137 | $9 |
| Hydrocodone-Acetaminophen | 15 | $78 | $5 |
Money from drug and device companies
$16 in 2024
| 2024 | 1 | 1 | None | $16 |
| 2023 | 1 | 1 | None | $21 |
| 2022 | 3 | 18 | None | $324 |
| 2021 | 5 | 38 | None | $625 |
| 2020 | 4 | 6 | None | $127 |
| 2019 | 6 | 23 | None | $311 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $16 | 1 payment
|
See the published payment
| Abbvie | Meals · 2024-10-22 | Rinvoq | $16 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $21
| Abbvie | Mavyret | $21 | 1 payment
|
2022: $324
| Abbvie | Humira | $280 | 16 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $25 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $20 | 1 payment
|
2021: $625
| AbbVie | Humira | $292 | 23 payments
|
| Janssen Biotech | Stelara | $164 | 5 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $112 | 7 payments
|
| Celgene | Zeposia | $44 | 2 payments
|
| RedHill Biopharma | Talicia | $13 | 1 payment
|
2020: $127
| Gilead Sciences | None | $54 | 2 payments
|
| AbbVie | Humira | $37 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $21 | 1 payment
|
| Janssen Biotech | Stelara | $14 | 1 payment
|
2019: $311
| Takeda Pharmaceuticals U.S.A. | Entyvio | $136 | 11 payments
|
| Allergan | Zenpep | $56 | 4 payments
|
| Gilead Sciences | None | $52 | 4 payments
|
| AbbVie | Humira | $32 | 2 payments
|
| Shionogi | Mulpleta | $20 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $16 | 1 payment
|
Professional record
- NPI
- 1053334698
- Licence
- CA G20286California G20286: Current · expires 2027-03-31
- Trained
- Harvard Medical School, 1967
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G202860
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 15899 Los Gatos Almaden Rd Ste 11, Los Gatos, CA, 95032
- NPI first listed
- 2006-07-25
- NPI last updated
- 2022-07-06
- NPI record certified
- 2022-07-06
This is when the NPI record was last certified, not a medical board exam.